Roles of T lymphocytes in pulmonary fibrosis
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Infiltration of T lymphocytes in the lungs is common in patients with and in animal models of pulmonary fibrosis. The role of these cells in regulating the accumulation of extracellular matrix, particularly collagen, is not understood completely. Research literature provides evidence for a profibrotic, an antifibrotic, or no significant role of T lymphocytes in pulmonary fibrosis. This review offers a discussion of such evidence with the focus on phenotypes of pulmonary T lymphocytes and related profibrotic and antifibrotic mechanisms. It appears unlikely that T lymphocytic infiltration per se is the central driving force in most cases of pulmonary fibrosis. Instead, evidence suggests that T lymphocytes may modulate the inflammatory and healing responses in the lungs in a profibrotic or antifibrotic manner, depending on their phenotype. Phenotypic reshaping, rather than elimination of the infiltrating pulmonary T lymphocytes, may be a promising approach to improving outcomes in patients with pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here, Th1 cells and their secretory products are thought of as being anti-fibrotic and Th2 cells and their mediators are considered pro-fibrotic (133).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [133]
Citations
Cites
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 2×
“new patients per year in the United States [2].”
BackgroundIdiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953 · cited 1×
“IL-17 enhances production of cytokines in cultured, pulmonary fibroblasts but appears to have no direct effect on fibroblast proliferation or collagen production [52].”
BackgroundA placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583 · cited 1×
“In contrast, different studies in the bleomycin model reported that depletion of T cells prevents collagen accumulation [34] or diminishes pulmonary fibrosis and increases survival [35].”
ResultA Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497 · cited 1×
“For example, activation of alveolar macrophages with type 2 cytokines skews their phenotype toward so-called alternative activation, and alternatively activated macrophages are themselves profibrotic [49] through production of various cytokines including profibrotic chemokines CCL2 [42] and CCL18 [50, 51].”
BackgroundBleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.
Szapiel, S. V., Elson, N., Fulmer, J. D., Hunninghake, G. W., & Crystal, R. G. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.893 · Cited by 463 · cited 1×
“Mice with genetic defects manifesting in a total lack of T lymphocytes, such as athymic (nude) mice [27] and SCID mice [28], developed alveolitis and pulmonary fibrosis in response to bleomycin, similar to that in normal (wild-type) mice.”
BackgroundDANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Mart�nez-Lav�n, M., Hermosillo, A. G., Rosas, M., & Soto, M.-E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1966::aid-art11>3.0.co;2-o · Cited by 306
Structural Features of Interstitial Lung Disease in Systemic Sclerosis
Harrison, N. K., Myers, A. R., Corrin, B., Soosay, G., Dewar, A., Black, C. M., Du Bois, R. M., & Turner-Warwick, M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.3_pt_1.706 · Cited by 251 · cited 2×
“Pulmonary fibrosis often occurs in association with systemic connective tissue diseases, particularly scleroderma [4, 12], rheumatoid arthritis (RA) [14], and polymyositis/dermatomyositis [15, 16].”
BackgroundAtamas, S. P., Yurovsky, V. V., Wise, R. A., Wigley, F. M., Robinson, C. J. G., Henry, P. A., Alms, W. J., & White, B. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1119::aid-anr8>3.0.co;2-3 · Cited by 216
Self-citationAtamas, S. P., Yurovsky, V. V., Wise, R. A., Wigley, F. M., Robinson, C. J. G., Henry, P. A., Alms, W. J., & White, B. (1999) · Arthritis & Rheumatism · Cited by 216
Self-citationRadiation Pneumonitis: A Possible Lymphocyte-mediated Hypersensitivity Reaction
Roberts, C. M., Foulcher, E., Zaunders, J. J., Bryant, D. H., Freund, J., Cairns, D., Penny, R., Morgan, G. W., & Breit, S. N. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00006 · Cited by 198 · cited 1×
“Such diseases include chronic hypersensitivity pneumonitis [19], sarcoidosis [20] and berylliosis [21], radiation-induced lung disease [22], and chronic GVHD [23].”
BackgroundMaggi, E., Cosmi, L., Liotta, F., Romagnani, P., Romagnani, S., & Annunziato, F. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.010 · Cited by 183 · cited 1×
“These cells produce TGF- (so-called Th3 cells) or bind active TGF- on their cell surface [57].”
BackgroundMarchal-Sommé, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., & Soler, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5735 · Cited by 179
Ishida, Y., Kimura, A., Kondo, T., Hayashi, T., Ueno, M., Takakura, N., Matsushima, K., & Mukaida, N. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.051213 · Cited by 169 · cited 1×
“For example, CD4 and especially CD8 T cells are capable of producing CCL3 (MIP-1 ) [40], and this chemokine is involved in pulmonary recruitment of fibrocytes in association with development of pulmonary fibrosis in an animal model [41].”
BackgroundSchrier, D. J., Phan, S. H., & McGarry, B. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.5.614 · Cited by 148
Hao, Z., Hampel, B., Yagita, H., & Rajewsky, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032196 · Cited by 139 · cited 1×
“In a genetically manipulated animal model, selective inactivation of Fas in T cells leads to a complex syndrome manifested by up-regulation of FasL on activated T cells, leukocyte infiltration in the lungs, and pulmonary fibrosis [43].”
BackgroundCytokine regulation of pulmonary fibrosis in scleroderma
Atamas, S. P., & White, B. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00060-1 · Cited by 122 · cited 6×
“Th cells (CD4 ) specialize in production of soluble factors (cytokines) that may act profibrotically (IL-4, IL-13, TGF- , oncostatin M) or antifibrotically (IFN- , TNF- ) [42].”
BackgroundSelf-citationT cell independence of bleomycin-induced pulmonary fibrosis
Helene, M., Lake-Bullock, V, Zhu, J., Hao, H., Cohen, D. A., & Kaplan, A. M. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.187 · Cited by 117
Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis
Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., Xing, Z., & Phan, S. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5470 · Cited by 114
Sempowski, G. D., Chess, P. R., & Phipps, R. P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4670 · Cited by 114 · cited 1×
“[45, 46].”
Luzina, I. G., Atamas, S. P., Wise, R., Wigley, F. M., Choi, J., Xiao, H. Q., & White, B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11080 · Cited by 111 · cited 7×
“The phenotype of pulmonary T cells in pulmonary fibrosis is consistent with a type 2 predominance, Tc2 in scleroderma lung disease [17, 18] and Th2 predominance in IPF [11, 13].”
BackgroundSelf-citationChizzolini, C., Parel, Y., De Luca, C., Tyndall, A., Åkesson, Scheja, A., & Dayer, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11129 · Cited by 110 · cited 2×
“Systemic sclerosis T cells may inhibit collagen production by fibroblasts via membrane-associated IFN- [54] or TNF- [ 55 ].”
BackgroundPulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies
Sauty, A., Rochat, T., Schoch, O. D., Hamacher, J., Kurt, A.-M., Dayer, J. M., & Nicod, L. P. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10122907 · Cited by 106 · cited 3×
“The CD4 /CD8 ratio was also decreased in the interstitium and BAL of patients with scleroderma lung disease [17, 18] and dermatomyositis/polymyositis [15, 16].”
BackgroundZhou, L., Askew, D. S., Wu, C., & Gilliam, A. C. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700517 · Cited by 103
Quigley, M., Wells, A. U., & Hansell, D. M. (2007) · CRC Press eBooks · doi:10.1201/b14634-14 · Cited by 96
Inflammatory Cell Phenotyping of the Pulmonary Interstitium in Idiopathic Interstitial Pneumonia
Parra, E. R., Kairalla, R. A., Ribeiro de Carvalho, C. R., Eher, E., & Capelozzi, V. L. (2007) · Respiration · doi:10.1159/000097133 · Cited by 95 · cited 1×
“The location of the T cell accumulation is greatest in the areas of lung tissue with interstitial fibrosis and honeycomb change, and there are only a few T cells present in areas of relatively normal tissue [8].”
BackgroundChristensen, P. J., Goodman, R. E., Pastoriza, L., Moore, B. B., & Toews, G. B. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65493-4 · Cited by 95 · cited 2×
“Similarly, SCID mice or mice that lack functional T cells in a different genetic model (RAG knockout) were equal to wildtype mice with normal T cell repertoires in their sensitivity to pulmonary fibrosis induced by intratracheal instillation of a chemical termed FITC [29].”
BackgroundRole of the Chemokine Receptors CXCR3 and CCR4 in Human Pulmonary Fibrosis
Pignatti, P., Brunetti, G., Moretto, D., Yacoub, M.-R., Fiori, M., Balbi, B., Balestrino, A., Cervio, G., Nava, S., & Moscato, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-244oc · Cited by 91 · cited 10×
“In agreement with these data, IPF patients with higher CD4/CD8 ratios in BAL fluid had a better response clinically to anti-inflammatory therapy than those with lower CD4/CD8 ratios [10].”
BackgroundInfluentialSharma, S. K., MacLean, J. A., Pinto, C., & Kradin, R. L. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.1.8680680 · Cited by 90 · cited 1×
“In contrast, different studies in the bleomycin model reported that depletion of T cells prevents collagen accumulation [34] or diminishes pulmonary fibrosis and increases survival [35].”
ResultIdentification of Pathogenic T Cells in Patients with Beryllium-Induced Lung Disease
Fontenot, A. P., Falta, M. T., Freed, B. M., Newman, L. S., & Kotzin, B. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1019 · Cited by 89
Complex Regulation of Pulmonary Inflammation and Fibrosis by CCL18
Pochetuhen, K., Luzina, I. G., Lockatell, V., Choi, J., Todd, N. W., & Atamas, S. P. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061167 · Cited by 87 · cited 8×
“Instead, they probably activate TGF- through a mechanism yet unknown [37, 38].”
BackgroundMethodResultSelf-citationCapelli, A., Stefano, A. D., Lusuardi, M., Gnemmi, I., & Donner, C. F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.2106084 · Cited by 75
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis
Daniil, Z., Kitsanta, P., Kapotsis, G., Mathioudaki, M., Kollintza, A., Karatza, M., Milic-Emili, J., Roussos, C., & Papiris, S. A. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-81 · Cited by 73 · cited 2×
“In IPF patients with surgical lung biopsies, increased numbers of CD8 T cells in lung tissue were associated with worse PFT parameters, increased shortness of breath, and worse gas exchange [ 7 ].”
BackgroundChizzolini, C., Rezzonico, R., Ribbens, C., Burger, D., Wollheim, F. A., & Dayer, J.-M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<2039::aid-art20>3.0.co;2-1 · Cited by 70 · cited 14×
“Activated T lymphocytes may produce proinflammatory mediators such as IFN- and TNF- as part of the overall inflammatory pattern.”
BackgroundInfluentialLung Fibrosis in Hypersensitivity Pneumonitis
Murayama, J.-I., Yoshizawa, Y., Ohtsuka, M., & Hasegawa, S. (1993) · CHEST Journal · doi:10.1378/chest.104.1.38 · Cited by 66 · cited 2×
“In sarcoidosis [20], beryliosis [21], RA [14], and hypersensitivity pneumonitis [ 19 ], CD4 T cells are predominant in the lungs of patients with pulmonary inflammation and fibrosis.”
BackgroundLuzina, I. G., Tsymbalyuk, N., Choi, J., Hasday, J. D., & Atamas, S. P. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20452 · Cited by 65 · cited 8×
“A systemic depletion of T cells in this model prevented collagen accumulation, despite the continuous expression of CCL18, suggesting that T cells were indeed the driving force of fibrosis [37].”
BackgroundSelf-citationSynergy Between CD40 Ligation and IL-4 on Fibroblast Proliferation Involves IL-4 Receptor Signaling
Atamas, S. P., Luzina, I. G., Dai, H., Wilt, S. G., & White, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1139 · Cited by 65 · cited 1×
“[45, 46].”
Self-citationBill, J. R., Mack, D. G., Falta, M. T., Maier, L. A., Sullivan, A. K., Joslin, F. G., Martin, A. D., Freed, B. M., Kotzin, B. L., & Fontenot, A. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.7029 · Cited by 64
Fireman, E., Vardinon, N., Burke, M., Spizer, S., Levin, S., Endler, A., Stav, D., Topilsky, M., Mann, A., Schwarz, Y., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11030706 · Cited by 64 · cited 9×
“In agreement with these data, IPF patients with higher CD4/CD8 ratios in BAL fluid had a better response clinically to anti-inflammatory therapy than those with lower CD4/CD8 ratios [10].”
BackgroundResultInfluentialIncreased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet
Xu, J., Mora, A. L., LaVoy, J., Brigham, K. L., & Rojas, M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00006.2006 · Cited by 63 · cited 2×
“It is therefore not surprising that recent studies discovered that mice deficient of T-bet were more susceptible to bleomycininduced pulmonary fibrosis than their wild-type counterparts [ 47 ].”
BackgroundResultUsual interstitial pneumonitis is a T-cell alveolitis
Kradin, R. L., Divertie, M. B., Colvin, R. B., Ramírez, J., Ryu, J. H., Carpenter, H. A., & Bhan, A. K. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90025-5 · Cited by 61 · cited 2×
“often distributed diffusely throughout the lung interstitium, whereas CD4 cells tend to be localized in lymphoid follicles [6, 9].”
BackgroundFibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium
Wells, A., Lorimer, S., Majumdar, S., Harrison, N., Corrin, B., Black, C., Jeffery, P., & du Bois, R. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08020266 · Cited by 60 · cited 3×
“Pulmonary fibrosis often occurs in association with systemic connective tissue diseases, particularly scleroderma [4, 12], rheumatoid arthritis (RA) [14], and polymyositis/dermatomyositis [15, 16].”
BackgroundOverexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis
Kimura, T., Ishii, Y., Yoh, K., Morishima, Y., Iizuka, T., Kiwamoto, T., Matsuno, Y., Homma, S., Nomura, A., Sakamoto, T., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051160 · Cited by 55 · cited 1×
“Consistent with the profibrotic effect of Th2 cells, overexpression of GATA-3 in mice resulted in a phenotype that was more susceptible to the induction of pulmonary fibrosis with bleomycin [48].”
BackgroundImpairment of Bleomycin-Induced Lung Fibrosis in CD28-Deficient Mice
Okazaki, T., Nakao, A., Nakano, H., Takahashi, F., Takahashi, K., Shimozato, O., Takeda, K., Yagita∥, H., & Okumura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1977 · Cited by 54
Luzina, I. G., Papadimitriou, J. C., Anderson, R., Pochetuhen, K., & Atamas, S. P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21950 · Cited by 52 · cited 12×
“A systemic depletion of T cells in this model prevented collagen accumulation, despite the continuous expression of CCL18, suggesting that T cells were indeed the driving force of fibrosis [37].”
BackgroundMethodSelf-citationCorsini, E., Luster, M. I., Mahler, J., Craig, W. A., Blazka, M. E., & Rosenthal, G. J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.5.7946383 · Cited by 49
PKCα Mediates CCL18-Stimulated Collagen Production in Pulmonary Fibroblasts
Luzina, I. G., Highsmith, K., Pochetuhen, K., Nacu, N., Rao, J. N., & Atamas, S. P. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0033oc · Cited by 44 · cited 1×
“For example, activation of alveolar macrophages with type 2 cytokines skews their phenotype toward so-called alternative activation, and alternatively activated macrophages are themselves profibrotic [49] through production of various cytokines including profibrotic chemokines CCL2 [42] and CCL18 [50, 51].”
BackgroundSelf-citationT lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice.
Suzuki, N., Ohta, K., Horiuchi, T., Takizawa, H., Ueda, T., Kuwabara, M., Shiga, J., & Ito, K. (1996) · Thorax · doi:10.1136/thx.51.10.1036 · Cited by 42 · cited 1×
“Infiltration of T lymphocytes also occurs in protein tyrosine phosphatase (Src homology 2-containing tyrosine phosphatase 1)-deficient (motheaten) mice [24], hapten-immune pulmonary interstitial fibrosis [25], and silicainduced pulmonary inflammation and fibrosis [26].”
BackgroundThe perforin mediated apoptotic pathway in lung injury and fibrosis
Miyazaki, H., Kuwano, K., Yoshida, K., Maeyama, T., Yoshimi, M., Fujita, M., Hagimoto, N., Yoshida, R., & Nakanishi, Y. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015495 · Cited by 39 · cited 1×
“Mediators of another apoptotic pathway, perforin and granzyme B, were up-regulated in infiltrating lymphocytes in lung tissue from IPF patients, compared with normal controls, and that the degree of inflammation and fibrosis was decreased following bleomycin instillation in perforin knockout mice [44].”
BackgroundGrob, M., Schmid‐Grendelmeier, P., Joller‐Jemelka, H. I., Ludwig, E., Dubs, R. W., Grob, P. J., Wüthrich, B., & Bisset, L. R. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00035.x · Cited by 38 · cited 1×
“For example, CD4 and especially CD8 T cells are capable of producing CCL3 (MIP-1) [ 40 ], and this chemokine is involved in pulmonary recruitment of fibrocytes in association with development of pulmonary fibrosis in an animal model [41].”
BackgroundKourakata, H., Takada, T., Suzuki, E., Enomoto, K., Saito, I., Taguchi, Y., Tsukada, H., Nakano, M., & Arakawa, M. (1999) · Respirology · doi:10.1046/j.1440-1843.1999.00179.x · Cited by 37 · cited 3×
“The CD4 /CD8 ratio was also decreased in the interstitium and BAL of patients with scleroderma lung disease [17, 18] and dermatomyositis/polymyositis [15, 16].”
BackgroundLeblond, V., Zouabi, H., Sutton, L., Guillon, J., Mayaud, C. M., Similowski, T., Beigelman‐Aubry, C., & Autran, B. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921436 · Cited by 36
Motheaten mice--an animal model with an inherited form of interstitial lung disease.
Rossi, G., Hunninghake, G. W., Kawanami, O., Ferrans, V. J., Hansen, C. T., & Crystal, R. G. (1985) · PubMed · doi:10.1164/arrd.1985.131.1.150 · Cited by 28 · cited 1×
“Infiltration of T lymphocytes also occurs in protein tyrosine phosphatase (Src homology 2-containing tyrosine phosphatase 1)-deficient (motheaten) mice [24], hapten-immune pulmonary interstitial fibrosis [25], and silicainduced pulmonary inflammation and fibrosis [26].”
BackgroundHu, H., & Stein‐Streilein, J. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.5.414 · Cited by 27 · cited 1×
“Infiltration of T lymphocytes also occurs in protein tyrosine phosphatase (Src homology 2-containing tyrosine phosphatase 1)-deficient (motheaten) mice [24], hapten-immune pulmonary interstitial fibrosis [25], and silicainduced pulmonary inflammation and fibrosis [26].”
BackgroundShimizu, Y., Kuwabara, H., Ono, A., Higuchi, S., Hisada, T., Dobashi, K., Utsugi, M., Mita, Y., & Mori, M. (2006) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970600809389 · Cited by 26 · cited 2×
“usually represent the majority [6–9, 13].”
BackgroundJanick‐Buckner, D., Ranges, G. E., & Hacker, M. P. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90295-0 · Cited by 23 · cited 1×
“Systemic depletion of T lymphocytes in the bleomycin [33] or FITC [29] pulmonary fibrosis models failed to affect the extent or severity of lung damage.”
BackgroundAskew, D. S., Zhou, L., Wu, C., Chen, G., & Gilliam, A. C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700813 · Cited by 18
Bronchoalveolar lavage in rheumatoid arthritis and secondary sjögren’s syndrome
Popp, W., Ritschka, L., Scherak, O., Braun, O., Kolarz, G., Rauscher, H., & Zwick, H. (1990) · Lung · doi:10.1007/bf02719696 · Cited by 18 · cited 3×
“Pulmonary fibrosis often occurs in association with systemic connective tissue diseases, particularly scleroderma [4, 12], rheumatoid arthritis (RA) [14], and polymyositis/dermatomyositis [15, 16].”
BackgroundNathan, N., Berdah, L., & Clément, A. (2021) · European Respiratory Society eBooks · doi:10.1183/9781849841313.007919 · Cited by 1
Research works printed but not linked: 1
- Huaux, 2007, ThIL-17 cells contribute to alveolitis but are not instrumental in fibrosis development, Am. J. Respir. Crit. Care Med., 175, A737
Cited by
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Regulation of inflammation by interleukin-4: a review of "alternatives"
Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A. W., Shea-Donohue, T., & Atamas, S. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412214 · Cited by 351
Self-citationImmune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
T Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 330
“However, the functions of each T cell subset appear to be perplexing and are influenced by interactions with epithelial cells or fibroblasts, the pulmonary localization of fibrosis in the bronchial or alveolar region, and the disease progression stage (9, 10).”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“Here, Th1 cells and their secretory products are thought of as being anti-fibrotic and Th2 cells and their mediators are considered pro-fibrotic (133).”
Background
Metadata
- Authors
- Luzina, I. G., Todd, N. W., Iacono, A. T., & Atamas, S. P.
- Affiliations
- Baltimore VA Medical Center (US)
- Corresponding author
- Atamas, Sergei P
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-25
- Volume
- 83
- Issue
- 2
- Pages
- 237-244
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2164998164
- Cited by
- 163
- References
- 59
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 13 · 2017: 9 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 10 · 2012: 12
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1R01HL074067)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- pulmonary fibrosis, T cells, T cell phenotype, extracellular matrix accumulation, collagen deposition, antifibrotic mechanism, lung inflammation
- MeSH terms
- Animals, Connective Tissue Diseases, Disease Models, Animal, Extracellular Matrix, Humans, Inflammation, Lymphocyte Depletion, Lymphokines, Mice, Nude, Pulmonary Fibrosis, T-Lymphocyte Subsets, Mice, SCID, Lung Diseases, Interstitial, CD28 Antigens, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.